Literature DB >> 20118383

28-year-old woman with rapidly progressive shortness of breath. Diagnosis: CSS.

Douglas L Nguyen1, Eva M Carmona, Randall S Edson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20118383      PMCID： PMC2813828          DOI： 10.4065/mcp.2009.0041

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  10 in total

1.  Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.

Authors:  M G Danieli; M Cappelli; G Malcangi; F Logullo; A Salvi; G Danieli
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

2.  Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome.

Authors:  Pedro Giavina-Bianchi; Mara Giavina-Bianchi; Rosana Agondi; Jorge Kalil
Journal:  J Allergy Clin Immunol       Date:  2007-03-08       Impact factor: 10.793

3.  Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.

Authors:  L Guillevin; B Jarrousse; C Lok; F Lhote; J P Jais; D Le Thi Huong Du; A Bussel
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

Review 4.  Eosinophilic lung diseases.

Authors:  J N Allen; W B Davis
Journal:  Am J Respir Crit Care Med       Date:  1994-11       Impact factor: 21.405

5.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

Review 6.  Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review.

Authors:  A L Katzenstein
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

7.  Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.

Authors:  Régis Sablé-Fourtassou; Pascal Cohen; Alfred Mahr; Christian Pagnoux; Luc Mouthon; David Jayne; Daniel Blockmans; Jean-François Cordier; Philippe Delaval; Xavier Puechal; Dominique Lauque; Jean-François Viallard; Abdelkader Zoulim; Loïc Guillevin
Journal:  Ann Intern Med       Date:  2005-11-01       Impact factor: 25.391

Review 8.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

9.  Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

Authors:  L Guillevin; P Cohen; M Gayraud; F Lhote; B Jarrousse; P Casassus
Journal:  Medicine (Baltimore)       Date:  1999-01       Impact factor: 1.889

Review 10.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.